Village doctor care with telemedicine to prevent stroke in older adults in rural China
Tests a village doctor and telemedicine care model in older adults at high stroke risk.
Plain-language title generated from the registry record
Registry title: A Novel Rural Integrated Care and Early Prevention Model for Older Adults at High Risk of or Living With Stroke in China
Key facts
- Where
- Suqian, ChinaSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for rural adults aged 65 or older in China who are at high risk of stroke or have had a stroke or TIA. It tests a care model led by village doctors with telemedicine support.
- Age
- 65 years or older
- Sex
- All sexes can join.
- Disease stage
- High risk of stroke (3 or more risk factors on the national "8+2" screening tool) or a past stroke or TIA.
Main reasons for not taking part
- Severe dementia or psychiatric disorder that prevents follow-up
- Life expectancy less than 1 year (for example advanced cancer or end-stage kidney disease)
- Currently taking part in another interventional clinical trial
Read by machine on 9 November 2026.
Where in China
- Jiangsu Province （Suqian）HospitalSuqian, ChinaTaking people
- Suqian Hospital Affiliated to Jiangsu Provincial People's HospitalSuqian, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jiangsu Province (Suqian) Hospital
- Trial code
- NCT07628283
- Record updated
- 26 August 2026
- Original description
This cluster randomized controlled trial aims to evaluate the effectiveness of a novel telemedicine-enabled integrated care model led by rural doctors in reducing cardiovascular and cerebrovascular events among elderly adults (≥65 years) at high risk of stroke in rural China. A total of 39 village clinics will be randomized to either the intervention group (digital health platform-supported integrated care) or the control group (enhanced usual care). The primary outcome is a composite of cardiovascular death, stroke, and hospitalization for heart failure or acute coronary syndrome at 36 months.Read full original descriptionShow less
A Prospective, Open-Label, Cluster Randomized Controlled Trial to Evaluate the Efficacy of a Rural Doctor-Led, Telemedicine-Supported Integrated Care Model for Reducing Cardiovascular and Cerebrovascular Events in Elderly Adults at High Risk of Stroke in China
This cluster randomized controlled trial aims to evaluate the effectiveness of a novel telemedicine-enabled integrated care model led by rural doctors in reducing cardiovascular and cerebrovascular events among elderly adults (≥65 years) at high risk of stroke in rural China. A total of 39 village clinics will be randomized to either the intervention group (digital health platform-supported integrated care) or the control group (enhanced usual care). The primary outcome is a composite of cardiovascular death, stroke, and hospitalization for heart failure or acute coronary syndrome at 36 months.
Inclusion: Aged 65 years or older; Rural residents with household registration or long-term residence (≥6 months/year) in the study area; High risk of stroke as defined by the National Health Commission's "8+2" stroke risk screening tool: ≥3 risk factors OR history of stroke/TIA; Willing to receive long-term health management from the assigned village clinic; Written informed consent provided by the participant or their legal representative.
Exclusion: Severe dementia or psychiatric disorder that prevents completion of study follow-up and assessments; Life expectancy less than 1 year (e.g., advanced malignancy, end-stage renal disease); Currently participating in another interventional clinical trial.